E
Evonik
Global specialty chemicals for various industrial applications
About Evonik
You might not know Evonik, but its products are likely in your car, your running shoes, and even your animal feed. Evonik is a global specialty chemicals company, meaning it creates the high-value, innovative ingredients that make thousands of everyday products better. The company's story isn't a typical startup tale. Evonik Industries was formally established on September 12, 2007, as part of a major restructuring of RAG AG, the German coal mining conglomerate. There were no individual founders in the traditional sense; instead, Evonik was created by the RAG Foundation. This foundation was established to manage the long-term financial liabilities from the decline of Germany's hard coal mining industry. Evonik's profits were intended to help fund these "perpetual costs." Evonik's chemical roots, however, run much deeper, tracing back to predecessor companies like Degussa, founded in 1873. RAG acquired Degussa in 2006, making it the core of its future industrial activities. When Evonik was formed, it initially held RAG's chemical, energy, and real estate assets. However, a strategic pivot two years later saw the company focus exclusively on its most profitable division: specialty chemicals. This sharpened focus led to an IPO on the Frankfurt and Luxembourg stock exchanges in April 2013. In the years since, Evonik has grown through strategic acquisitions, strengthening its position in high-margin markets. Today, Evonik operates in over 100 countries as a leader in specialty chemicals. The company is currently undergoing a significant restructuring to improve efficiency and has paused major acquisitions until 2027 to focus on this internal transformation and growth.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2007
- Headquarters
- Essen, Germany
- Listing
- IPO 2013
- Employees
- 14,737
- Open positions
- None listed
- Dealroom signal
- 35.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Farming, Biotechnology, Chemistry, Non-Invasive medical devices and treatments, Innovation Radar, Specialty Chemicals, Manufacturing, EIT InnoEnergy
- Technology
- 3D Technology, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 21 companies, latest Apr 2024
- Capital deployed
- $83M
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO CONVERTIBLE✓Other financing | Jun 2026 | $413M | — | Undisclosed | ↗ |
| POST IPO DEBT✓Debt | Sep 2025 | $550M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Evonik is 460 monthly website visits, down 98.3% over the last three months. Evonik's team grew 1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
VeloxRosh Haayin, IsraelVelox develops and manufactures industrial-grade direct-to shape digital decoration solutions for the rigid container industry
$152Mvaluation
TC
Thai Peroxide CoThailand
→
Novachem SrlBeccar, Argentina
→
Hefei Haizhou New MaterialChinaGraphene-based nanomaterials for high-performance battery applications
→
Allay TherapeuticsMenlo Park, United StatesOffers analgesic products for post-surgical pain management and recuperation
$230Mvaluation
Infinitec BarcelonaSpainProviding customers with strictly necessary cookies
→
JeNaCellJena, GermanyManufactures nanostructures used for medical and cosmetic purposes
$3.1Mvaluation
LACTELHoover, United StatesLACTEL Absorbable Polymers - Biodegradable polymers & polymer-based technologies
$15Mvaluation
Uniontech3dSongjiang District, ChinaShanghai Union Technology Corporation
→
PorocelHouston, United StatesPorocel - Catalyst Services, Activated Alumina & Specialty Adsorbents | Porocel
$210Mvaluation
InnoHealthMadrid, SpainInnoHealth Groupis focused on the development of novel Skin Care products oriented to treat dermatological diseases
→
Structured PolymersAustin, United StatesStructured Polymers produces specialty polymer materials for the additive manufacturing industry
$6Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Innovation Connections
Series B and later3 investors entered at this stage
CVC Capital Partners
Temasek
European Investment Bank
Other known investors1 additional known investor
Fundación Parque Científico de Madrid
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evonik on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evonik’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







